Analytical Data
-
Gene name
PRAC
- Application
-
Alternative Names
PRAC；C17orf92；PRAC；Small nuclear Protein PRAC1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96KF2
-
Expression Region
1-57aa
-
AA Sequence
MLCAHFSDQG PAHLTTSKSA FLSNKKTSTL KHLLGETRSD GSACNSGISG GRGRKIP
-
Molecular Weight
5.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of PRAC (Protein Receptor-Associated Complex) recombinant proteins has gained significant attention in recent years due to their crucial role in various biological processes and therapeutic applications. PRACs are involved in mediating cellular responses to external stimuli, playing vital roles in signaling pathways that regulate cell growth, differentiation, and apoptosis. The ability to produce recombinant forms of these proteins allows researchers to dissect their functions and mechanisms in detail, thus contributing to our understanding of complex cellular interactions. Moreover, recombinant PRACs serve as valuable tools in drug discovery and development, providing insights into potential therapeutic targets for diseases such as cancer, cardiovascular disorders, and neurological conditions. Advances in molecular biology techniques have facilitated the cloning, expression, and purification of PRACs, enabling high-throughput production and functional characterization. As a result, the investigation of PRAC recombinant proteins is not only essential for elucidating fundamental biological questions but also for the advancement of clinical therapies and biotechnological applications, underscoring the importance of ongoing research in this field.
